QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
Log in
NASDAQ:ATRI

Atrion Stock Forecast, Price & News

$700.00
-15.11 (-2.11 %)
(As of 01/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$690.11
Now: $700.00
$714.76
50-Day Range
$615.50
MA: $661.88
$736.00
52-Week Range
$567.00
Now: $700.00
$755.00
Volume3,920 shs
Average Volume7,645 shs
Market Capitalization$1.30 billion
P/E Ratio39.44
Dividend Yield0.98%
Beta0.13
Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Germany, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise MPS2 Myocardial Protection System that delivers fluids and medications, mixes critical drugs, and controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Atrion logo

MarketRank

Overall MarketRank

0.94 out of 5 stars

Medical Sector

1021st out of 1,925 stocks

Surgical & Medical Instruments Industry

98th out of 169 stocks

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 1.7Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ATRI
CUSIP04990410
Phone(972) 390-9800
Employees616
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$155.07 million
Cash Flow$24.48 per share
Book Value$128.24 per share

Profitability

Net Income$36.76 million

Miscellaneous

Market Cap$1.30 billion
Next Earnings Date2/24/2021 (Estimated)
OptionableNot Optionable
$700.00
-15.11 (-2.11 %)
(As of 01/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ATRI News and Ratings via Email

Sign-up to receive the latest news and ratings for ATRI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Atrion (NASDAQ:ATRI) Frequently Asked Questions

How has Atrion's stock been impacted by COVID-19?

Atrion's stock was trading at $667.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ATRI stock has increased by 4.9% and is now trading at $700.00.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Atrion?

Wall Street analysts have given Atrion a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Atrion wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is David A. Batta's approval rating as Atrion's CEO?

1 employees have rated Atrion CEO David A. Batta on Glassdoor.com. David A. Batta has an approval rating of 100% among Atrion's employees. This puts David A. Batta in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

When is Atrion's next earnings date?

Atrion is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for Atrion
.

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) posted its quarterly earnings results on Monday, November, 9th. The medical instruments supplier reported $3.95 earnings per share for the quarter. The medical instruments supplier had revenue of $33.79 million for the quarter. Atrion had a net margin of 21.90% and a trailing twelve-month return on equity of 13.90%.
View Atrion's earnings history
.

How often does Atrion pay dividends? What is the dividend yield for Atrion?

Atrion declared a quarterly dividend on Friday, November 13th. Investors of record on Tuesday, December 1st will be paid a dividend of $1.75 per share on Tuesday, December 15th. This represents a $7.00 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date of this dividend is Monday, November 30th.
View Atrion's dividend history
.

Is Atrion a good dividend stock?

Atrion pays an annual dividend of $7.00 per share and currently has a dividend yield of 0.98%.
View Atrion's dividend history.

Who are some of Atrion's key competitors?

What other stocks do shareholders of Atrion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include International Paper (IP), AT&T (T), WestRock (WRK), AbbVie (ABBV), Caterpillar (CAT), Eastman Chemical (EMN), Gilead Sciences (GILD), Altria Group (MO), Pfizer (PFE) and Philip Morris International (PM).

Who are Atrion's key executives?

Atrion's management team includes the following people:
  • Mr. Emile A. Battat, Exec. Chairman (Age 82, Pay $620.35k)
  • Mr. David A. Battat, Pres & CEO (Age 50, Pay $1.44M)
  • Mr. Jeffery Strickland, VP, CFO, Treasurer & Sec. (Age 61, Pay $654.38k)

What is Atrion's stock symbol?

Atrion trades on the NASDAQ under the ticker symbol "ATRI."

Who are Atrion's major shareholders?

Atrion's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Boston Trust Walden Corp (1.42%), Hudson Valley Investment Advisors Inc. ADV (0.03%) and Nisa Investment Advisors LLC (0.02%). Company insiders that own Atrion stock include Emile A Battat, John P Stupp Jr and Ronald Nicholas Spaulding.
View institutional ownership trends for Atrion
.

Which institutional investors are selling Atrion stock?

ATRI stock was sold by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp.
View insider buying and selling activity for Atrion
or view top insider-selling stocks.

Which institutional investors are buying Atrion stock?

ATRI stock was purchased by a variety of institutional investors in the last quarter, including Hudson Valley Investment Advisors Inc. ADV, and Nisa Investment Advisors LLC.
View insider buying and selling activity for Atrion
or or view top insider-buying stocks.

How do I buy shares of Atrion?

Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Atrion's stock price today?

One share of ATRI stock can currently be purchased for approximately $700.00.

How big of a company is Atrion?

Atrion has a market capitalization of $1.30 billion and generates $155.07 million in revenue each year. Atrion employs 616 workers across the globe.

What is Atrion's official website?

The official website for Atrion is www.atrioncorp.com.

How can I contact Atrion?

Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The medical instruments supplier can be reached via phone at (972) 390-9800 or via email at [email protected]

This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.